DBV -  France Stock  

EUR 8.48  0.82  8.82%

DBV TECHNOLOGIES is trading at 8.48 as of the 17th of October 2021, a -8.82 percent down since the beginning of the trading day. The stock's open price was 9.3. DBV TECHNOLOGIES has only a 6 % chance of going through financial distress over the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for DBV TECHNOLOGIES are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of September 2021 and ending today, the 17th of October 2021. Click here to learn more.
 Market Performance
3 of 100
  Odds Of Distress
Less than 6
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. DBV TECHNOLOGIES operates under Biotechnology classification in France and is traded on Paris Stock Exchange. The company has 54.9 M outstanding shares. More on DBV TECHNOLOGIES
Follow Valuation Odds of Bankruptcy
Check how we calculate scores


Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. DBV TECHNOLOGIES's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DBV TECHNOLOGIES or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
DBV TECHNOLOGIES has very high historical volatility over the last 90 days
The company reported the revenue of 4.4 M. Net Loss for the year was (130.54 M) with profit before overhead, payroll, taxes, and interest of 11.28 M.
DBV TECHNOLOGIES has accumulated about 125.48 M in cash with (142.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.28.
CEOMarieCatherine Therene  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of DBV TECHNOLOGIES's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldFairly Valued
DBV TECHNOLOGIES (DBV) is traded on Paris Stock Exchange in France and employs 97 people. The company currently falls under 'Small-Cap' category with current market capitalization of 483.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DBV TECHNOLOGIES's market, we take the total number of its shares issued and multiply it by DBV TECHNOLOGIES's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. DBV TECHNOLOGIES operates under Healthcare sector and is part of Biotechnology industry. The entity has 54.9 M outstanding shares. DBV TECHNOLOGIES has accumulated about 125.48 M in cash with (142.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.28.
Check DBV TECHNOLOGIES Probability Of Bankruptcy
DBV TECHNOLOGIES retains a total of 54.9 Million outstanding shares. 30% of DBV TECHNOLOGIES outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Thus, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check DBV TECHNOLOGIES Ownership Details

DBV TECHNOLOGIES Stock Price Odds Analysis

What are DBV TECHNOLOGIES's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of DBV TECHNOLOGIES jumping above the current price in 90 days from now is about 76.03%. The DBV TECHNOLOGIES probability density function shows the probability of DBV TECHNOLOGIES stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon DBV TECHNOLOGIES has a beta of 0.654 suggesting as returns on the market go up, DBV TECHNOLOGIES average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding DBV TECHNOLOGIES will be expected to be much smaller as well. Additionally, the company has an alpha of 0.0822, implying that it can generate a 0.0822 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 8.48HorizonTargetOdds Up 8.48 
23.77%90 days
Based on a normal probability distribution, the odds of DBV TECHNOLOGIES to move above the current price in 90 days from now is about 76.03 (This DBV TECHNOLOGIES probability density function shows the probability of DBV TECHNOLOGIES Stock to fall within a particular range of prices over 90 days) .


Investors will always prefer to have the highest possible return on investment while minimizing volatility. DBV TECHNOLOGIES market risk premium is the additional return an investor will receive from holding DBV TECHNOLOGIES long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DBV TECHNOLOGIES. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although DBV TECHNOLOGIES's alpha and beta are two of the key measurements used to evaluate DBV TECHNOLOGIES's performance over the market, the standard measures of volatility play an important role as well.

DBV TECHNOLOGIES Stock Against Markets

Picking the right benchmark for DBV TECHNOLOGIES stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in DBV TECHNOLOGIES stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for DBV TECHNOLOGIES is critical whether you are bullish or bearish towards DBV TECHNOLOGIES at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in DBV TECHNOLOGIES without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Insider Screener Now


Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

DBV TECHNOLOGIES Corporate Directors

DBV TECHNOLOGIES corporate directors refer to members of a DBV TECHNOLOGIES board of directors. The board of directors generally takes responsibility for the DBV TECHNOLOGIES's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of DBV TECHNOLOGIES's board members must vote for the resolution. The DBV TECHNOLOGIES board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Pascale Ehouarn - Industrial Development and Production DirectorProfile
Claude Thebault - Medical DirectorProfile
Viviane Monges - Non-Executive Independent DirectorProfile
Claire Giraut - Non-Executive Independent DirectorProfile
Continue to Investing Opportunities. Note that the DBV TECHNOLOGIES information on this page should be used as a complementary analysis to other DBV TECHNOLOGIES's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Tools for DBV TECHNOLOGIES Stock

When running DBV TECHNOLOGIES price analysis, check to measure DBV TECHNOLOGIES's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DBV TECHNOLOGIES is operating at the current time. Most of DBV TECHNOLOGIES's value examination focuses on studying past and present price action to predict the probability of DBV TECHNOLOGIES's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move DBV TECHNOLOGIES's price. Additionally, you may evaluate how the addition of DBV TECHNOLOGIES to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance